|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 December 2020 |
|
Main ID: |
NCT02438748 |
|
Date of registration:
|
06/05/2015 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Biological Markers of Treatment Response to Repetitive Transcranial Magnetic Stimulation for Depression
|
|
Scientific title:
|
The Role of Biological Stress Markers in Predicting Treatment Response to Repetitive Transcranial Magnetic Stimulation in Major Depressive Disorder |
|
Date of first enrolment:
|
May 2015 |
|
Target sample size:
|
310 |
|
Recruitment status: |
Enrolling by invitation |
|
URL:
|
https://clinicaltrials.gov/show/NCT02438748 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
Canada
| | | | | | | |
|
Contacts
|
|
Name:
|
Mandana Modirrousta, MD PhD FRCPC |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University of Manitoba |
| | |
|
Key inclusion & exclusion criteria
|
Patient Inclusion Criteria:
- Patients with a major depressive episode
- Not actively receiving psychotherapy
Patient Exclusion Criteria:
- History of a psychotic episode
- History of neurological illness
- Head injury
- Active alcohol or substance abuse
- History of a seizure disorder
- Pregnant
Control Subject Exclusion Criteria:
- History of depression or psychiatric illness
- History of a psychotic episode
- History of neurological illness
- Head injury
- Active alcohol or substance abuse
- History of a seizure disorder
- Pregnant
Age minimum:
18 Years
Age maximum:
80 Years
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Oxidative Stress
|
|
Intervention(s)
|
|
Device: Repetitive Transcranial Magnetic Stimulation
|
|
Primary Outcome(s)
|
|
Change in Oxidized Phosphatidylcholines in plasma
[Time Frame: 3 weeks]
|
|
Secondary ID(s)
|
|
B2014:102
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|